Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-30 | Dr. Scott has held leadership positions for over 30 years in the world’s leading biopharma companies, including J&J, Pfizer, Amgen and AbbVie. Dr. Scott received his BSc in Microbiology and Biochemistry and MbChB in Medicine from the University of Cape Town. |
| 2022-05-11 | Dr. Scott’s extensive experience leading large biopharmaceutical companies through several successful product developments provides him with the qualifications and skills to serve on our Board. |
| 2023-01-10 | Robert Scott, M.D. |
| 2023-06-30 | Dr. Scott received his BSc in Microbiology and Biochemistry and MbChB in Medicine from the University of Cape Town. |
| 2024-03-12 | Robert Scott, M.D.(4) - Includes 100 shares of common stock and options to purchase 750 shares of common stock exercisable within 60 days of February 20, 2024. |
Data sourced from SEC filings. Last updated: 2025-10-11